Item 5. Market for Registrant’s Common Equity
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities.
Market
Information for Common Stock
On
February 12, 2025 our Common Stock began trading on the Nasdaq Capital Markets under the ticker symbol “AGH”. Prior to
that time, there was no public trading market for our Common Stock. AGH”. We had 10,880,000 shares of Common Stock issued and
outstanding as of December 31, 2024.
Holders
of Capital Stock
As of December 31, 2024, we had 3 registered
holders of our Common Stock. This number does not include stockholders for whom shares are held in “nominee” or “street”
name. The actual number of holders of our Common Stock is greater than this number of record holders, and includes stockholders who are
beneficial owners, but whose shares are held in street name by brokers or held by other nominees.
As
of December 31, 2024, we had 3 registered holders of our Class A Preferred Stock. There is no established public trading market for our
Class A Preferred Stock.
Transfer
Agent
The
transfer agent for our Common Stock is VStock Transfer, LLC. The transfer agent’s telephone number and address is (212) 828-8436
and 18 Lafayette Place Woodmere, New York 11598.
Dividends
To
date, we have not declared or paid any dividends on our Common Stock. We currently do not anticipate paying any cash dividends in the
foreseeable future on our Common Stock. Although we intend to retain our earnings, if any, to finance the exploration and growth of our
business, the board of directors of the Company (the “Board) has the discretion to declare and pay dividends in the future.
Payment
of dividends in the future will depend upon our earnings, capital requirements, and any other factors that our Board deems relevant.
Recent
Sales of Unregistered Securities
Except
as set forth below or in a Current Report on Form 8-K, there were no equity securities of the registrant sold by the registrant
during the period covered by this annual report that were not registered under the Securities Act.
Use
of Proceeds from the IPO
The
offering pursuant to our IPO terminated after the sale of all securities registered pursuant to the Registration Statement. On Form S-1
filed in connection with our IPO.
36
Further,
there has been no material change in the expected use of the net proceeds from our IPO as described under the heading “Use of Proceeds”
in our final prospectus, filed with the SEC on February 13, 2025, pursuant to Rule 424(b)(4) relating to our registration statement on
Form S-1.
The
net proceeds from our IPO were approximately $10.6 million, after deducting underwriting discounts and commissions and offering
expenses and a portion of which were used $2,464,768 to make payments towards the 2014 Loans, 2024 Loans, and Expense Loan (all of
which are defined herein). For more information, see “Item 13. Certain Relationships and Related Transactions, and Director
Independence.” As of the date of this Annual Report, there has been no material change in the planned proceeds from our IPO,
as described in our final prospectus.
Purchases
of Equity Securities by the Issuer and Affiliated Purchasers
None.
Item 6. [Reserved]
Smaller
reporting companies are not required to provide the information required by this item.